Currently holds positions in Mallinckrodt Plc, Recro Pharma Inc and Aclaris Therapeutics Inc
Position | Company | Period |
---|---|---|
Chief Financial Officer, Executive Vice President | Mallinckrodt Plc | March 18, 2019 - |
Independent Director | Recro Pharma Inc | March 3, 2017 - |
Independent Director | Aclaris Therapeutics Inc | April 20, 2018 - |
Chief Financial Officer, Senior Vice President - Finance | Amneal Pharmaceuticals Inc | Dec. 12, 2012 - Jan. 1, 2018 |
Acting Chief Financial Officer, Vice President - Finance | Amneal Pharmaceuticals Inc | June 29, 2012 - Dec. 12, 2012 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-08-28 | 2023-08-28 |
Recro Pharma Inc
(REPH)
|
B Purchase |
62,500
+27.3%
0.4025,000 USD |
62,500 +27.3% | 0.40 | 25,000 USD | |
2020-12-07 | 2020-12-03 |
Mallinckrodt Plc
(MNK)
|
S Sale |
5,400
-31.8%
0.17891 USD |
5,400 -31.8% | 0.17 | 891 USD | |
2019-06-07 | 2019-06-07 |
Mallinckrodt Plc
(MNK)
|
B Purchase |
5,400
+42.9%
8.9648,383 USD |
5,400 +42.9% | 8.96 | 48,383 USD |